The flash glucose monitoring (FGM) system FreeStyle Libre® is a device that measures interstitial glucose in a very simple way and indicates direction and speed of glucose change. This allows persons with diabetes to prevent hypoglycemic and hyperglycemic events. Scientific evidence indicates that the system can improve glycemic control and quality of life. To obtain the maximum benefit, it is necessary to properly handle glucose values and trends. Due to the generalization of the system use, the purpose of the document is to provide recommendations for the optimal use of the device, not only in the management of glucose values and trends but also in the prevention of hypoglycemia, actuation in exercise, special situations, and retrospective analysis of the glucose data, among others.
Glucose monitoring is one of the key elements in diabetes management; especially for insulin treated patients. Most of patients rely exclusively on self-monitoring of blood glucose (SMBG) through the use of finger-stick blood samples, test strips, and glucose meters. However, SMBG offers only limited glucose information.
In 2014, the flash glucose monitoring (FGM) system (FreeStyle Libre®; Abbot Diabetes Care, Witney, Oxon, UK), which measures intermittent interstitial glucose (IG), was marketed in Spain. With this system, IG monitoring has become widespread for patients, particularly those on insulin therapy. The need to establish guidelines for optimal use of this system is evident as clinical experience and scientific evidence continue to grow and given its incorporation into health care system's coverage in many countries including Spain.
Through painless scans, FGM facilitates more glucose readings. This increase in glucose data should in turn:
• • Improve glycemic control and reduction of hypoglycemias. • • Decrease glucose variability.
• • Improve quality of life and treatment satisfaction.
All of these benefits could contribute to decrease mortality and chronic complications in the long term, however there is no evidence in this point at present time.
Clinical experience and scientific data suggest that FGM provides clinical benefits in:
• • Improvement in blood glucose due to more number of glucose measurements. • • Reduction of SMBG readings required for glucose control. • • Reduction in the number and duration of hypoglycemia and hyperglycemia events.
When FGM is compared to plasma blood glucose (BG) shows adequate accuracy for clinical decision making. 1 However, IG is different from BG particularly in situations when glucose changes rapidly. Changes in IG are seen with a delay of ≈5 minutes in relation to BG in the FGM system. 2 The system provides predictive (trend arrows) and retrospective information from the last 8 hours. Retrospective information includes estimated glycosylated hemoglobin (HbA1c), monthly pooled profile, glycemic variability, glucose average, proportion of values above, below, and in target (70-180 mg/dL), number and duration of hypoglycemic events, daily profiles, number of SMBGs, number of scans, and so on. This information is very relevant if properly used. Therefore, the purpose of this document is to facilitate the optimal use of this tool through adequate training for patients and professionals.
To prepare this document, the available scientific evidence was reviewed, including similar international recommendations. 3, 4 Most of these were developed for continuous glucose monitoring (CGM) systems. [5] [6] [7] [8] [9] [10] This document provides general recommendations adjusted for FGM, which should be adapted to individual patient needs.
Treatment Adjustment Based on Trend Arrows

Prior Considerations
There are situations with a lower correlation between the IG provided by FGM and BG values: first 24 hours of use, in hypoglycemia and hyperglycemia, and when rapid changes of glucose occur (postprandial period, exercise, etc).
Therefore, SMBG measurements are recommended in some situations: when IG readings change rapidly, to confirm hypoglycemia and when symptoms do not correspond with IG value.
Therapeutic diabetes education is mandatory to obtain maximum benefits from the system. Patients must be instructed to scan at least every 8 hours, and to review retrospective data regularly. These actions are essential to detect patterns and to act accordingly. The main objectives of therapeutic diabetes education are addressed:
1. To establish individual glucose goals 2. To interpret arrows, adopt preventive actions and evaluate the impact of those actions through a new glucose reading. 3. To analyze the current situation before making decisions: insulin on board, food intake, postprandial period, exercise, stress, etc. 4. To make "step-by-step" changes with caution to avoid excessive corrections in both hyperglycemia and hypoglycemia. 5. To consider insulin administration 15-30 minutes before a meal, if glucose rises rapidly. 6. To consider insulin administration just before or after a meal, if glucose falls rapidly.
Trend Arrows
FGM system provides the current IG value with a trend arrow. The meaning of trend arrows is shown in Table 1 . 
Prandial Insulin Adjustments
To calculate a prandial bolus based on a trend one must consider the following: insulin on board from previous boluses, exercise, carbohydrate (CH) intake, glycemic index, and patient preferences and skills. Ideally, patients on intensified therapy should be able to calculate doses based on insulin to CH ratio (ICR) and insulin sensitivity factor (ISF), from preprandial IG and CH intake. However, some patients use fixed doses or with minimal changes based on preprandial IG and food intake. Table 2 shows the proposed adjustments in prandial insulin according to trend. For patients on fixed doses these adjustments are expressed as a percentage of usual doses, or as an increase/decrease in units according to their total daily dose of insulin. This table also shows recommendations for patients who calculate doses with ICR and ISFboth as a percentage and as an increase/decrease in units according to ISF.
Correction Bolus Adjustments
Several factors should be considered to calculate a correction bolus according to the trend including insulin on board, ISF, expected physical activity, and events (stress, prior hypoglycemia, etc). a) Insulin on board: It is important to prevent overlapping action of insulins that may later lead to hypoglycemia. b) Postprandial glucose target (2 hours): Values <180 mg/dL are the recommended general objective. Correction bolus must be calculated based on ISF. c) Trend: It is recommended to increase or decrease the calculated correction bolus in percentages-for patients using ISF-or in insulin units-for those using fixed doses. Table 3 shows the proposed adjustments.
To sum up, when elevated postprandial (2-4 h) IG is treated with a correction bolus: -Avoid corrections before 2 hours since prandial bolus administration. -Consider a correction if IG 2 hours after meal is ≥180 mg/dL (in individual cases, consider it with lower IG). -If a correction bolus has been administered, it is advised not to administer another one in the next 2 hours, monitoring IG during this time.
Hypoglycemia Prevention and Treatment
It is necessary to check glucose levels by SMBG both for diagnosis of hypoglycemia and after recovery due to the physiological delay between IG and BG. 
Do not adjust Do not adjust Do not adjust
The ranges shown are based on the median TDD used in our setting. **The calculated ranges are based on the median ISF used in our setting. ***Consider starting intake with 10-20 g of fast-absorbing CHs and not administering the insulin bolus until 15-30 minutes after the start of intake. It is recommended to repeat the glucose reading every 30 minutes, until glucose level normalizes and up to two hours after bolus administration. If glucose level <70 mg/dL or >180 mg/dL, add or subtract from the proposed units by standard calculation, usually provided by a bolus calculator (therefore incorporating ISF), the IUs indicated in the table.
In patients using insulin pens that do not allow half units to be administered, round up or down on an individual basis. Table 4 shows recommendations for prevention and management of hypoglycemia based on trend, in postprandial conditions and at baseline or interprandial periods.
Special Populations and Situations
Children
The pediatric population has special characteristics, requiring particular insulin adjustments. Young children are characterized by very high insulin sensitivity, especially in the second half of the morning with a marked anti-dawn phenomenon. By contrast, high insulin resistance and a marked dawn phenomenon characterize adolescents. 11 As there are no methods specifically designed for insulin adjustments in children using FGM, recommendations from the Endocrine Society 5 can be extrapolated. This is possible given the analogy of trend arrows between the FGM system and the system for which such methods were designed (adapted). 6 Table 5 shows recommendations for pediatric populations. 
70-100
Repeat reading in 10 minutes Intake of 15 g CH and repeat reading in 10 minutes: <70 mg/d and trend persists: -Confirm with SMBG -New intake of 20 g CH* <70
or Confirm with CG and take 20 g CH* Repeat CG in 10 minutes**: -If <70 mg/dL, intake of 15 g CH* -If >70 mg/dL, intake of 15 g of slow-absorbing CHs Confirm with CG and take 30 g CH* . Repeat SMBG in 10 minutes**: -If <70 mg/dL, intake of 15 g CH* -If >70 mg/dL, intake of 15 g of slow-absorbed CH *It is important to ensure the resolution of hypoglycemia with a SMBG measurement. Recovery may seem to be delayed if only IG is used. Thus, using IG only may lead to error and overcorrection of hypoglycemia. 
Continuous Subcutaneous Insulin Infusion (CSII) Users
As an alternative to modify prandial or correction boluses based on the trend, patients on CSII therapy can use a temporary basal rate (TBR), with the advantage that it may be discontinued or adjusted if trend changes. TBR duration as a general rule will be of at least two hours. The trend will be checked in 15-30 minutes, and if there is a sudden change in it, TBR will be modified or discontinued. Table 6 proposes TBR based on trend in prandial and postprandial conditions. To prevent hypoglycemia in the postprandial period (2-4 hours), use of TBR is proposed as follows:
-When IG is 100-150 mg/dL and tends to gradually decrease, repeat reading in 15-30 minutes.If the trend persists use a TBR (80%). -When IG is <100 mg/dL and tends to gradually decrease, consider intake of 10g of CH. -When IG is 100-150 mg/dL and tends to rapidly decrease, repeat reading in 15 minutes. If the trend persists, use a TBR (70%). -When IG is <100 mg/dL and tends to rapidly decrease, consider intake of 10-20 g of CH and stop CSII.
Other Situations a) Exercise
Exercise increases the risk of hypoglycemia both during and after its finalization. The type, intensity, duration, time of day, and individual response are variables affecting glucose response. Therefore, recommendations should be tailored. In all cases, a glucose reading should be performed before exercise. Table 7 includes general and initial recommendations for exercise.
b) Driving
A glucose reading is advisable before driving, looking at the trend: -IG on target with stable or slowly increasing trend: Do not take any action.
-IG on target but decreasing: A CH supplement should be taken. TBR with a percent reduction is an option in CSII users, or basal rate discontinuation.
-IG below target (hypoglycemia): Treatment before driving is advised. IG and trend should be checked again before driving. 
c) Illness or stress
Concomitant diseases or emotional stress tend to raise BG. Table 8 shows the recommendations for action facilitating the management of these situations.
Treatment Adjustment Based on Retrospective Data Analysis
Blood Glucose Measurement
General Considerations. Health care professionals should be familiar with a broader definition of optimal glycemic control including more than just HbA1c-a measure of central tendency. A combination of other variables reflects more realistically glucose control, especially regarding variability and risk of hyperglycemia and hypoglycemia. 12 Recommendations. Different consensuses have been published to standardize collection of glucometric data obtained with CGM. [13] [14] [15] Table 9 presents a proposal for recording these data, most of which can be obtained with the FGM system and Libreview® platform. Information that should be included in the clinical reports and considered in clinical decision making appears in bold.
The standardized summary of glucose data provided by CGM/FGM should be a part of the assessment of patients. To expedite data collection, in future updates of the software it would be desirable to have a summary similar to the one proposed in automatically generated reports.
AGP Analysis
Aspects to Consider. The AGP integrates changes in IG levels recorded over a given period of time into a graph. AGP groups all recordings by time of day-modal day. These data are represented using the median, 25th-75th, and 10th-90th percentiles (Figure 1 ). 16, 17 AGP is very useful to identify patterns, quantify variability, and stratify the risk of hypoglycemia at different time intervals. 18 Systematic Review of Results. It is recommended to follow an established order for AGP interpretation 19 (Figure 2 2. Understand the usual routine of the patient: • • Treatments, diet, exercise, and so on. Entry of these data into the system by the patient facilitates its interpretation.
3. Review the AGP profile for each part of the day: • • Interpret the median IG, its stability throughout the day and its behavior, above or below the target at different times (day, night, postprandial period).
Identify hypoglycemic patterns:
• • Identify when the 10th or 25th percentiles are close to the hypoglycemia limit-usually established at 70 mg/dL. A 10th percentile close to or crossing the cut-off represents a risk of hypoglycemia, being higher when is the 25th percentile close to or crossing the limit. • • Identify potential causes: diet and exercise, or consider reduce insulin dose before this period.
Analyze glycemic variability:
• • Glucose variability is measured by the interquartile range (between the 25th and 75th percentiles) ( Figure 1 ) preferably assessed at different times of the day. • • Identify potential causes: inadequate CH estimation or exercise management, omission of boluses, overcorrection of hypoglycemia, and so on.
6. Day-to-day analysis: • • Identify potential causes of variability, hypoglycemia, or hyperglycemia in different days.
7. The essential message(s) of data analysis should be summarized, as well as recommended actions. 8. Reassess after a given period of time depending on the actions suggested.
Summary. AGP is a very useful tool for analysis of FGM data because facilitates visual, accurate, and consistent identification of trends at different times of day, complementing information provided by HbA1c 21 . AGP allows professionals and patients to identify the effects of treatment adjustments or any given nonpharmacological intervention.
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